Rays opening day starter Zach Eflin placed on 15
ST. PETERSBURG, Fla. (AP) — The Tampa Bay Rays placed opening day starter Zach Eflin on the 15-day injured list with lower back inflammation before Monday night’s game against Boston.
Eflin has struggled this year after a strong first season with Tampa Bay in 2023, going 3-4 with a 4.12 ERA in 10 starts. The right-hander was 16-8 last year after signing a $40 million, three-year contract, which was the largest free-agent deal in Rays’ history.
Rays manager Kevin Cash said the goal is for Eflin to be back in two to four weeks, He won’t throw for a week.
“We’ll see how that goes,” Cash said. “I’m guessing it will all be symptom driven.”
Eflin, on the IL last season from April 11 to 23 because of lower back tightness, said the latest setback popped up late in his start Saturday in Toronto.
“Doesn’t feel great,” Eflin said. “It’s uncomfortable. Kind of happened last year and I felt good after about eight days.”
Related articles
David Ortiz is humbled by being honored in New York again; this time for post
NEWTON, Mass. (AP) — Hall of Famer David Ortiz is committed to his post-career work like he was swin2024-05-21Cristian Măcelaru to become music director of Cincinnati Symphony Orchestra in 2025
CINCINNATI (AP) — Cristian Măcelaru was hired Wednesday as music director of the Cincinnati Symphony2024-05-21North Carolina legislators return to adjust the budget and consider other issues
RALEIGH, N.C. (AP) — The North Carolina General Assembly is returning to regular business six months2024-05-21A portrait by Gustav Klimt has been sold for $32 million at an auction in Vienna
VIENNA (AP) — A portrait of a young woman by Gustav Klimt that was long believed to be lost was sold2024-05-21Dame Judi Dench's tears as she receives Sycamore Gap tree seedling at Chelsea Flower Show
Dame Judi Dench shed a tear yesterday after being presented with a seedling from the famous Sycamore2024-05-21The body types that raise the risk of colon cancer
Your body shape could be putting you at extra risk of one of the fastest growing cancers in young pe2024-05-21
atest comment